Curcugen® - Clinically studied, full-spectrum Turmeric for high-performance formulations
Group News

Curcugen® - Clinically studied, full-spectrum Turmeric for high-performance formulations

February 2026

ACI Group, in partnership with DolCas Biotech, supplies Curcugen®, a clinically validated, full-spectrum turmeric extract, to UK formulators and manufacturers.

Curcugen® preserves the native bioactives of turmeric, delivering a complete turmeric profile with superior absorption, efficacy, and safety - all without synthetic additives. It is designed to meet the demands of modern functional foods, beverages, and nutraceuticals.

View Article
Morikol® Marine Collagen – Clinically proven, low-dose, formulation-ready
ACI Group

Morikol® Marine Collagen – Clinically proven, low-dose, formulation-ready

February 2026

ACI Group urges brands to strengthen supplier oversight as regulatory and sustainability pressures intensify
Food

ACI Group urges brands to strengthen supplier oversight as regulatory and sustainability pressures intensify

January 2026

Why processing deserves a rethink
Food

Why processing deserves a rethink

January 2026

What is permissible indulgence, and what does it mean for us in 2026?
Food

What is permissible indulgence, and what does it mean for us in 2026?

January 2026

Turning reformulation into opportunity: How brands can thrive under the UK’s junk food ad ban
Food

Turning reformulation into opportunity: How brands can thrive under the UK’s junk food ad ban

January 2026

ACI Group criticises ‘blunt’ HFSS health scoring as fruit-based foods face new ad bans
Food

ACI Group criticises ‘blunt’ HFSS health scoring as fruit-based foods face new ad bans

January 2026